サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1414447

ニューロモデレーションの世界市場レポート 2024年

Neuromodulation Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ニューロモデレーションの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

ニューロモデレーションの市場規模は近年急速に拡大しています。2023年の64億3,000万米ドルから2024年には71億4,000万米ドルへと、CAGR11.1％で成長します。ニューロモデレーション分野の実績は、いくつかの要因によるところが大きいです。慢性疾患の有病率の増加、ニューロモデレーション治療を支持する臨床的エビデンスと研究の蓄積、非侵襲的治療オプションに対する患者からの需要の高まり、これらの進歩を支持する政府のイニシアティブと資金提供、これらの治療法の適応範囲の拡大、革新と開発を促進した業界内の協力関係やパートナーシップなどです。

ニューロモデレーション市場規模は、今後数年で急成長が見込まれます。2028年の年間平均成長率（CAGR）は10.5％で、106億4,000万米ドルに成長します。今後予想される成長には様々な要因が関連しており、特にデバイスの小型化、高齢化社会に蔓延する神経疾患への注目の高まり、精神医学におけるアプリケーションの増加、患者中心の治療アプローチ、ヘルスケアアクセスの世界的拡大などが挙げられます。

神経疾患の有病率の増加は、ニューロモデレーション市場の成長を促す重要な要因となっています。これらの疾患には、脳、神経、脊髄に影響を及ぼすさまざまな問題が含まれます。ニューロモデレーションによる介入は、アルツハイマー病、パーキンソン病、てんかんを含む様々な神経疾患を管理・調節するための有望な手段を提供します。2022年4月に開催された欧州脳会議（European Brain Council）の報告書では、世界全体で600を超える神経疾患と300近くの精神疾患が報告されており、アルツハイマー病やその他の認知症の患者数は5,000万人に達しています。世界中で6,500万人が罹患しているてんかんは、神経疾患の重大な影響を強調しています。欧州における認知症患者数は、2050年までに1,050万人から1,870万人へと大幅に増加すると予測されており、これらの深刻化する健康問題に対処する上で、ニューロモデレーションが極めて重要な役割を果たすことを示しています。

ヘルスケア支出の増加は、ニューロモデレーション市場の成長を促進します。ヘルスケア支出には、サービス、保険、調査、公衆衛生イニシアチブなど、さまざまな健康関連活動への支出が含まれます。ヘルスケア支出の増加は、神経疾患に対する革新的な治療法や診断法の進歩や採用を促進します。財源の充実はまた、新規技術の広範な調査を支え、その有効性、安全性、精度を高めています。注目すべきは、Office for National Statistics（国家統計局）によると、2020年から2021年にかけての英国のヘルスケア支出は名目で9.4％、実質で9.7％増加すると報告されていることです。さらに、予防医療支出は2021年に457億2,000万米ドルに急増し、前年の2倍以上に増加しており、ニューロモデレーション市場の成長に大きく貢献していることを示しています。

2023年のニューロモデレーション市場で最大の地域は北米でした。ニューロモデレーション市場レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のニューロモデレーション市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 体内ニューロモデレーション
  • 体外ニューロモデレーション（非侵襲的）
  • 世界のニューロモデレーション市場、生体材料別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ポリマー生体材料
  • 金属生体材料
  • セラミック生体材料
  • 世界のニューロモデレーション市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 慢性の痛み
  • 尿失禁と便失禁
  • 片頭痛
  • フェイルドバック症候群
  • パーキンソン病
  • てんかん
  • 身震い
  • うつ
  • その他の用途
  • 世界のニューロモデレーション市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 病院
  • クリニック
  • 在宅ヘルスケア

第7章 地域および国の分析

  • 世界のニューロモデレーション市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界のニューロモデレーション市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ニューロモデレーション市場の競合情勢
  • ニューロモデレーション市場の企業プロファイル
    • Abbott Laboratories
    • Soterix Medical Inc.
    • Boston Scientific Corporation
    • Medtronic plc
    • Synapse Biomedical Inc.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r11957

“Neuromodulation Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neuromodulation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neuromodulation? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The neuromodulation market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Technology: Internal Neuromodulation; External Neuromodulation (Non-invasive)
  • 2) By Biomaterial: Polymeric Biomaterial; Metallic Biomaterial; Ceramic Biomaterial
  • 3) By Application: Chronic Pain; Urinary And Fecal Incontinence; Migraine; Failed Back Syndrome; Parkinson Disease; Epilepsy; Tremor; Depression; Other Applications
  • 4) By End-User: Hospitals; Clinics; Home Healthcare
  • Companies Mentioned: Abbott Laboratories; Soterix Medical Inc.; Boston Scientific Corporation; Medtronic plc; Synapse Biomedical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Neuromodulation refers to the adjustment of nerve activity through electrical or pharmacological means, directly targeting specific areas. It's a reversible method employed to alleviate pain.

The primary technologies in neuromodulation include internal and external methods. Internal neuromodulation involves implanting an electrode near a targeted nerve and administering a low-voltage electric current. Biomaterials used encompass polymeric, metallic, and ceramic materials. These technologies are applied in treating various conditions such as chronic pain, urinary and fecal incontinence, migraine, failed back syndrome, Parkinson's disease, epilepsy, tremor, depression, and more. They find use across multiple settings including hospitals, clinics, and home healthcare environments.

The neuromodulation market research report is one of a series of new reports from The Business Research Company that provides neuromodulation market statistics, including the neuromodulation industry's global market size, regional shares, competitors with a neuromodulation market share, detailed neuromodulation market segments, market trends, and opportunities, and any further data you may need to thrive in the neuromodulation industry. This neuromodulation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuromodulation market size has grown rapidly in recent years. It will grow from $6.43 billion in 2023 to $7.14 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. Historical growth in the field of neuromodulation can be largely attributed to several factors. These include the increasing prevalence of chronic disorders, the accumulation of clinical evidence and research supporting neuromodulation therapies, a growing demand from patients for non-invasive treatment options, government initiatives and funding supporting these advancements, the widening scope of indications for these therapies, as well as collaborations and partnerships within the industry that fostered innovation and development.

The neuromodulation market size is expected to see rapid growth in the next few years. It will grow to $10.64 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. Anticipated growth in the upcoming period is linked to various factors, notably the miniaturization of devices, a heightened focus on neurological disorders prevalent in the aging population, increased applications in psychiatry, patient-centric approaches in treatment, and the global expansion of healthcare access.

The increasing prevalence of neurological disorders stands as a significant driver for the growth of the neuromodulation market. These disorders encompass a wide range of issues affecting the brain, nerves, and spinal cord. Neuromodulation interventions offer promising avenues for managing and regulating various neurological conditions, including Alzheimer's, Parkinson's, and epilepsy. Reports from the European Brain Council in April 2022 highlighted over 600 neurological diseases and nearly 300 psychiatric conditions globally, with 50 million individuals affected by Alzheimer's and other dementias. Epilepsy, affecting 65 million people worldwide, underscores the substantial impact of neurological disorders. Projections indicate a substantial rise in dementia cases in Europe, from 10.5 million to 18.7 million by 2050, signifying the pivotal role of neuromodulation in addressing these escalating health concerns.

The upward trajectory of healthcare expenditures is poised to drive the growth of the neuromodulation market. Healthcare expenditure encompasses spending on various health-related activities, including services, insurance, research, and public health initiatives. Increased healthcare spending facilitates the advancement and adoption of innovative therapies and diagnostic methods for neurological disorders. Enhanced financial resources also support extensive research into novel neuromodulation technologies, enhancing their effectiveness, safety, and precision. Notably, the Office for National Statistics reported a 9.4% nominal increase and a 9.7% real-term rise in healthcare spending in the UK between 2020 and 2021. Moreover, preventive care spending surged to $45.72 billion in 2021, more than doubling from the previous year, indicating a significant contribution to the growth of the neuromodulation market.

Technological advancements emerge as a pivotal trend shaping the neuromodulation market. Major players in this sector are dedicated to pioneering innovative technological solutions to fortify their market positions. For instance, Abbott's December 2022 launch of the Eterna spinal cord stimulation (SCS) system, featuring the smallest implantable, rechargeable spinal cord stimulator, illustrates the pursuit of advancements. Incorporating patented low-dose BurstDR stimulation, this system demonstrates superior pain relief compared to conventional approaches. Additionally, Abbott's NeuroSphere Virtual Clinic, launched in March 2021, represents a pioneering technology allowing remote patient-clinician interactions for optimizing treatment settings and exploring new therapeutic options. Approved by the US FDA, this initiative broadens access to effective treatment for chronic pain or Parkinson's disease, particularly beneficial during circumstances such as the COVID-19 pandemic.

Major players in the neuromodulation market are focusing on introducing next-generation devices with advanced features, such as the implantable pulse generator (IPG), to gain a competitive edge. For example, CVRx's November 2022 launch of the Barostim Neo2 IPG, an upgraded version of its neuromodulation device for heart failure treatment, exemplifies this pursuit. With improved efficiency, reduced size, and enhanced design facilitating easier implantation, the Barostim Neo2 retains the clinically proven Barostim therapy, emphasizing the drive towards patient-friendly, durable, and efficient solutions in neuromodulation.

In March 2022, Electromedical Products International Inc (EPI), a prominent US-based medical device manufacturer, completed the acquisition of Pulvinar Neuro LLC for an undisclosed sum. This strategic acquisition empowers EPI to further its progress in advancing patented technologies, notably transcranial alternating current stimulation (tACS), enhancing personalized feedback stimulation, and expanding its cloud-enabled digital therapeutics for psychiatric and neurological conditions. Pulvinar Neuro, a US-based neurotechnology company, specializes in leveraging cutting-edge technologies to support neuroscience research, aligning seamlessly with EPI's objectives in advancing medical innovation in this domain.

Major companies operating in the neuromodulation market report are Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, Neuropace Inc., LivaNova PLC, Neurosigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, ReShape Lifesciences Inc., Inspire Medical Systems Inc., Bioventus LLC, Saluda Medical Pty Ltd., Otolith Labs Inc., Machine Medicine Inc., Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuronoff ApS, Neuros Medical Inc., Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., Magic Leap Inc., Omron Corporation

North America was the largest region in the neuromodulation market in 2023. The regions covered in the neuromodulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the neuromodulation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The neuromodulation market includes revenues earned by entities through sacral nerve stimulation for pelvic disorders and incontinence, deep brain stimulation (DBS) treatment for Parkinson's disease, and spinal cord stimulation for ischemic disorders (angina, peripheral vascular disease). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Neuromodulation Market Characteristics

3. Neuromodulation Market Trends And Strategies

4. Neuromodulation Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Neuromodulation Market Size and Growth

  • 5.1. Global Neuromodulation Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Neuromodulation Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Neuromodulation Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Neuromodulation Market Segmentation

  • 6.1. Global Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Internal Neuromodulation
  • External Neuromodulation (Non-invasive)
  • 6.2. Global Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Polymeric Biomaterial
  • Metallic Biomaterial
  • Ceramic Biomaterial
  • 6.3. Global Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Chronic Pain
  • Urinary And Fecal Incontinence
  • Migraine
  • Failed Back Syndrome
  • Parkinson Disease
  • Epilepsy
  • Tremor
  • Depression
  • Other Applications
  • 6.4. Global Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Home Healthcare

7. Neuromodulation Market Regional And Country Analysis

  • 7.1. Global Neuromodulation Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Neuromodulation Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Neuromodulation Market

  • 8.1. Asia-Pacific Neuromodulation Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Neuromodulation Market

  • 9.1. China Neuromodulation Market Overview
  • 9.2. China Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Neuromodulation Market

  • 10.1. India Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Neuromodulation Market

  • 11.1. Japan Neuromodulation Market Overview
  • 11.2. Japan Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Neuromodulation Market

  • 12.1. Australia Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Neuromodulation Market

  • 13.1. Indonesia Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Neuromodulation Market

  • 14.1. South Korea Neuromodulation Market Overview
  • 14.2. South Korea Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Neuromodulation Market

  • 15.1. Western Europe Neuromodulation Market Overview
  • 15.2. Western Europe Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Neuromodulation Market

  • 16.1. UK Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Neuromodulation Market

  • 17.1. Germany Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Neuromodulation Market

  • 18.1. France Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Neuromodulation Market

  • 19.1. Italy Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Neuromodulation Market

  • 20.1. Spain Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Neuromodulation Market

  • 21.1. Eastern Europe Neuromodulation Market Overview
  • 21.2. Eastern Europe Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Neuromodulation Market

  • 22.1. Russia Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Neuromodulation Market

  • 23.1. North America Neuromodulation Market Overview
  • 23.2. North America Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Neuromodulation Market

  • 24.1. USA Neuromodulation Market Overview
  • 24.2. USA Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Neuromodulation Market

  • 25.1. Canada Neuromodulation Market Overview
  • 25.2. Canada Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Neuromodulation Market

  • 26.1. South America Neuromodulation Market Overview
  • 26.2. South America Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Neuromodulation Market

  • 27.1. Brazil Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Neuromodulation Market

  • 28.1. Middle East Neuromodulation Market Overview
  • 28.2. Middle East Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Neuromodulation Market

  • 29.1. Africa Neuromodulation Market Overview
  • 29.2. Africa Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Neuromodulation Market Competitive Landscape And Company Profiles

  • 30.1. Neuromodulation Market Competitive Landscape
  • 30.2. Neuromodulation Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Soterix Medical Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Boston Scientific Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Medtronic plc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Synapse Biomedical Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Neuromodulation Market Competitive Benchmarking

32. Global Neuromodulation Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Neuromodulation Market

34. Neuromodulation Market Future Outlook and Potential Analysis

  • 34.1 Neuromodulation Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Neuromodulation Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Neuromodulation Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer